BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 12031904)

  • 1. Substitution of isoleucine-31 by helical-breaking proline abolishes oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide.
    Kanski J; Aksenova M; Schöneich C; Butterfield DA
    Free Radic Biol Med; 2002 Jun; 32(11):1205-11. PubMed ID: 12031904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity: implications for neurodegeneration in Alzheimer's disease brain. A review.
    Butterfield DA
    Free Radic Res; 2002 Dec; 36(12):1307-13. PubMed ID: 12607822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of glycine-33 and methionine-35 in Alzheimer's amyloid beta-peptide 1-42-associated oxidative stress and neurotoxicity.
    Kanski J; Varadarajan S; Aksenova M; Butterfield DA
    Biochim Biophys Acta; 2002 Mar; 1586(2):190-8. PubMed ID: 11959460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The hydrophobic environment of Met35 of Alzheimer's Abeta(1-42) is important for the neurotoxic and oxidative properties of the peptide.
    Kanski J; Aksenova M; Butterfield DA
    Neurotox Res; 2002 May; 4(3):219-23. PubMed ID: 12829402
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro and in vivo oxidative stress associated with Alzheimer's amyloid beta-peptide (1-42).
    Yatin SM; Varadarajan S; Link CD; Butterfield DA
    Neurobiol Aging; 1999; 20(3):325-30; discussion 339-42. PubMed ID: 10588580
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Rodent Abeta(1-42) exhibits oxidative stress properties similar to those of human Abeta(1-42): Implications for proposed mechanisms of toxicity.
    Boyd-Kimball D; Sultana R; Mohmmad-Abdul H; Butterfield DA
    J Alzheimers Dis; 2004 Oct; 6(5):515-25. PubMed ID: 15505374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neurotoxicity and oxidative stress in D1M-substituted Alzheimer's A beta(1-42): relevance to N-terminal methionine chemistry in small model peptides.
    Boyd-Kimball D; Sultana R; Mohmmad-Abdul H; Butterfield DA
    Peptides; 2005 Apr; 26(4):665-73. PubMed ID: 15752582
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Methionine residue 35 is critical for the oxidative stress and neurotoxic properties of Alzheimer's amyloid beta-peptide 1-42.
    Butterfield DA; Kanski J
    Peptides; 2002 Jul; 23(7):1299-309. PubMed ID: 12128086
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Solution NMR studies of the A beta(1-40) and A beta(1-42) peptides establish that the Met35 oxidation state affects the mechanism of amyloid formation.
    Hou L; Shao H; Zhang Y; Li H; Menon NK; Neuhaus EB; Brewer JM; Byeon IJ; Ray DG; Vitek MP; Iwashita T; Makula RA; Przybyla AB; Zagorski MG
    J Am Chem Soc; 2004 Feb; 126(7):1992-2005. PubMed ID: 14971932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simulations of monomeric amyloid β-peptide (1-40) with varying solution conditions and oxidation state of Met35: implications for aggregation.
    Brown AM; Lemkul JA; Schaum N; Bevan DR
    Arch Biochem Biophys; 2014 Mar; 545():44-52. PubMed ID: 24418316
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Different mechanisms of oxidative stress and neurotoxicity for Alzheimer's A beta(1--42) and A beta(25--35).
    Varadarajan S; Kanski J; Aksenova M; Lauderback C; Butterfield DA
    J Am Chem Soc; 2001 Jun; 123(24):5625-31. PubMed ID: 11403592
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Attenuated cytotoxicity but enhanced betafibril of a mutant amyloid beta-peptide with a methionine to cysteine substitution.
    Dai XL; Sun YX; Jiang ZF
    FEBS Lett; 2007 Apr; 581(7):1269-74. PubMed ID: 17349630
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Solution conformations and aggregational properties of synthetic amyloid beta-peptides of Alzheimer's disease. Analysis of circular dichroism spectra.
    Barrow CJ; Yasuda A; Kenny PT; Zagorski MG
    J Mol Biol; 1992 Jun; 225(4):1075-93. PubMed ID: 1613791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of methionine-35 oxidation on the aggregation of amyloid-β peptide.
    Friedemann M; Helk E; Tiiman A; Zovo K; Palumaa P; Tõugu V
    Biochem Biophys Rep; 2015 Sep; 3():94-99. PubMed ID: 29124171
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The critical role of methionine 35 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity.
    Butterfield DA; Boyd-Kimball D
    Biochim Biophys Acta; 2005 Jan; 1703(2):149-56. PubMed ID: 15680223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Methionine does not reduce Cu(II)-beta-amyloid!--rectification of the roles of methionine-35 and reducing agents in metal-centered oxidation chemistry of Cu(II)-beta-amyloid.
    da Silva GF; Lykourinou V; Angerhofer A; Ming LJ
    Biochim Biophys Acta; 2009 Jan; 1792(1):49-55. PubMed ID: 19061952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of phenylalanine 20 in Alzheimer's amyloid beta-peptide (1-42)-induced oxidative stress and neurotoxicity.
    Boyd-Kimball D; Mohmmad Abdul H; Reed T; Sultana R; Butterfield DA
    Chem Res Toxicol; 2004 Dec; 17(12):1743-9. PubMed ID: 15606152
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation among secondary structure, amyloid precursor protein accumulation, and neurotoxicity of amyloid beta(25-35) peptide as analyzed by single alanine substitution.
    Sato K; Wakamiya A; Maeda T; Noguchi K; Takashima A; Imahori K
    J Biochem; 1995 Dec; 118(6):1108-11. PubMed ID: 8720122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Modification of amyloid-β1-42 fibril structure by methionine-35 oxidation.
    Hou L; Lee HG; Han F; Tedesco JM; Perry G; Smith MA; Zagorski MG
    J Alzheimers Dis; 2013; 37(1):9-18. PubMed ID: 23719512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Temporal relations among amyloid beta-peptide-induced free-radical oxidative stress, neuronal toxicity, and neuronal defensive responses.
    Yatin SM; Aksenova M; Aksenov M; Markesbery WR; Aulick T; Butterfield DA
    J Mol Neurosci; 1998 Dec; 11(3):183-97. PubMed ID: 10344789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.